Methimazole (Tapazole) Cost in Connecticut 2026

At a glance
- Cash price (generic) / ~$15/month at CT retail pharmacies in 2026
- Manufacturer list price (Tapazole/Pfizer generics) / ~$80/month
- Compounded methimazole (503A pharmacy) / $0, $10/month for eligible patients
- Connecticut Medicaid coverage / Yes, with prior authorization (PA)
- Telehealth prescribing / Legal in Connecticut
- Typical dose forms / Oral tablet, 5 mg or 10 mg
- Dosing frequency / Once or twice daily
- Brand name / Tapazole (Pfizer; generic equivalents widely available)
- Primary indication / Hyperthyroidism, Graves disease
- Prescription required / Yes (prescription only)
What Does Methimazole Cost in Connecticut Without Insurance?
Generic methimazole costs approximately $15 per month at Connecticut retail pharmacies when paid in cash in 2026. That figure applies to the most common doses, 5 mg and 10 mg tablets, purchased at chains such as CVS, Walgreens, and Stop and Shop with a GoodRx or similar coupon applied. Without any discount, shelf price at the same pharmacies can run $40 to $60 per month for generic product. Branded Tapazole carries a manufacturer list price near $80 per month, though most prescribers and patients use generic versions today.
Methimazole is a thioamide antithyroid agent approved by the FDA for hyperthyroidism, including Graves disease. The FDA prescribing information lists initial dosing typically at 15 mg to 60 mg per day in divided doses for moderate to severe hyperthyroidism, tapering once euthyroidism is achieved [1]. Daily dose determines monthly pill count and therefore cost, so patients on high initial doses may pay somewhat more per month than the $15 median.
A 2005 review by Cooper in the New England Journal of Medicine described methimazole as the preferred antithyroid drug over propylthiouracil (PTU) for most adults because of a more favorable dosing schedule and a lower risk of severe hepatotoxicity [2]. That preference is now reflected in multiple guidelines, which means demand for generic methimazole remains high and competitive pricing at Connecticut pharmacies is stable.
Price comparison tools such as GoodRx, NeedyMeds, and the RxSaver app all show Connecticut-specific pricing. Entering your ZIP code and desired dose pulls real-time quotes from pharmacies within a few miles.
How Connecticut Medicaid Covers Methimazole
Connecticut Medicaid (HUSKY Health) covers methimazole with prior authorization. Prior authorization (PA) for antithyroid drugs under HUSKY typically requires documentation of a confirmed diagnosis of hyperthyroidism or Graves disease, usually a TSH below the reference range plus an elevated free T4 or T3, along with a prescriber attestation [3]. Most endocrinologists and primary care physicians in Connecticut are familiar with this process, and approval is routinely granted within one to five business days.
Once PA is approved, HUSKY members generally pay $0 to $3 per prescription fill at the point of sale, making Medicaid the lowest-cost pathway for eligible Connecticut residents. The Connecticut HUSKY Health formulary is updated quarterly, and methimazole remains on Tier 1 or equivalent preferred status in most managed-care plans under the program [3].
Patients who are uninsured or underinsured may qualify for the ConnPACE program or for manufacturer patient-assistance programs. The American Thyroid Association guidelines recommend thyroid function testing every four to six weeks during dose titration, so ongoing lab costs should be factored into the total treatment budget, not just the drug itself [4].
Is Compounded Methimazole Legal in Connecticut?
Yes. Compounded methimazole is legally available in Connecticut through state-licensed 503A pharmacies. A 503A pharmacy compounds medications for individual patients based on a valid prescription from a licensed prescriber, and Connecticut's Department of Consumer Protection licenses and inspects these facilities under state pharmacy law aligned with federal USP Chapter 795 standards [5].
Compounding is most common when a patient needs a dose not commercially available, such as 2.5 mg tablets for fine titration, a liquid formulation for patients who cannot swallow tablets, or a transdermal gel sometimes used in veterinary patients. The cost of compounded methimazole in Connecticut ranges from $0 (when covered under some Medicaid or assistance programs) to roughly $25 to $40 per month depending on the formulation and the pharmacy.
The FDA distinguishes between 503A pharmacies (patient-specific compounding) and 503B outsourcing facilities (large-scale compounding) [6]. Connecticut residents obtaining compounded methimazole should confirm their pharmacy holds a valid 503A state license; the Connecticut Department of Consumer Protection maintains a public lookup tool for licensed pharmacies.
The decision framework our medical team uses at HealthRX for Connecticut patients considering compounded methimazole follows three criteria: (1) Is a commercially available tablet strength adequate for the prescribed dose? If yes, generic tablets are preferred for consistency. (2) Does the patient have a documented swallowing difficulty or allergy to a tablet excipient? If yes, a compounded liquid may be appropriate. (3) Has the prescriber confirmed the 503A pharmacy's Connecticut license number? Prescribers should record the license number in the chart before transmitting the compound order.
Can You Get Methimazole via Telehealth in Connecticut?
Telehealth prescribing of methimazole is legal in Connecticut. State law permits licensed Connecticut prescribers to initiate and manage antithyroid therapy via synchronous audio-visual telehealth visits, provided the prescriber has established a valid patient-provider relationship and appropriate diagnostic workup has been completed [7].
Thyroid function labs, specifically TSH, free T4, and, when Graves disease is suspected, TSH receptor antibodies, must be on file before a prescriber issues an initial methimazole prescription via telehealth. Connecticut does not require an in-person physical exam before telehealth prescribing for this category of medication [7]. Most telehealth platforms, including HealthRX, coordinate lab orders with local draw sites such as Quest Diagnostics or LabCorp locations in Hartford, New Haven, Bridgeport, Stamford, and Waterbury.
Follow-up monitoring is equally important. The American Thyroid Association's 2016 guidelines specify checking a CBC with differential and liver function tests at baseline and if a patient develops fever, sore throat, or jaundice, given the rare but serious risks of agranulocytosis and hepatotoxicity with methimazole [4]. These labs can be ordered and reviewed remotely, making ongoing telehealth management practical for stable patients across Connecticut.
Patients living in rural Connecticut counties, including Windham and Tolland, benefit particularly from telehealth access because endocrinology wait times at academic centers in Hartford or New Haven can exceed two to three months [8].
Which Insurance Plans Cover Methimazole in Connecticut?
Most commercial insurance plans sold in Connecticut cover generic methimazole. Insurers operating in the state include Anthem Blue Cross Blue Shield, Aetna (which is headquartered in Hartford), UnitedHealthcare, Cigna, and ConnectiCare. Across these plans, methimazole typically sits on Tier 1 (preferred generic), meaning copays run $5 to $15 per month fill for most members [9].
Prior authorization requirements vary by plan. Anthem and ConnectiCare have historically placed antithyroid drugs on a PA-exempt tier for members with a documented endocrinology diagnosis code on file. Aetna and Cigna may request a simple step-edit confirming that the diagnosis is confirmed hyperthyroidism before approving coverage at Tier 1 rates. Patients should call the member services number on the back of their insurance card and ask specifically whether NDC codes for methimazole 5 mg or 10 mg tablets require PA under their specific plan year [9].
The American Association of Clinical Endocrinologists 2022 updated hyperthyroidism guidelines recommend antithyroid drug therapy as a first-line option for Graves disease in many patient groups, a designation that strengthens PA approval requests when insurers seek clinical justification [10].
Out-of-network pharmacies and specialty mail-order pharmacies may carry different copay tiers. Asking your insurer specifically about 90-day mail-order supply pricing often reduces per-dose cost by 20 to 33 percent compared to 30-day retail fills.
Discount Programs and Savings Cards for Methimazole in Connecticut
Several discount pathways can bring methimazole costs below the already-low $15 per month cash price. GoodRx coupons at Connecticut pharmacies have shown prices as low as $9 per month for a 30-day supply of generic methimazole 10 mg tablets at major chains [11]. RxSaver and Blink Health offer comparable discounts at many of the same locations.
For branded Tapazole, Pfizer's patient-assistance program provides free or reduced-cost medication to patients who meet income criteria, generally at or below 400 percent of the federal poverty level. Applications are submitted through the Pfizer RxPathways program and processing typically takes two to four weeks. Connecticut residents should note that RxPathways can be used even when the patient has insurance, if their copay exceeds a threshold Pfizer defines annually.
NeedyMeds.org lists additional Connecticut-specific pharmaceutical assistance programs updated monthly. The CDC's chronic disease prevention resources also point toward state-level assistance for patients managing ongoing endocrine conditions [12].
For patients on Graves disease treatment requiring 18 to 24 months of continuous methimazole therapy, as described in the Cooper 2005 NEJM review [2], even a $5 per month difference in drug cost adds up to $90 to $120 over a typical treatment course. Optimizing the discount program used at prescription initiation pays dividends over the full remission attempt.
Dosing, Monitoring, and Total Cost of Care in Connecticut
Methimazole dosing begins high and tapers. The FDA-approved labeling recommends 15 mg per day for mild hyperthyroidism, 30 to 40 mg per day for moderate disease, and up to 60 mg per day for severe disease, given in three divided doses initially [1]. Once TSH normalizes, doses are typically reduced to a maintenance range of 5 to 10 mg per day [1].
Higher initial doses mean more tablets per month and slightly higher pharmacy costs. A patient starting at 40 mg per day takes eight 5 mg tablets daily, or roughly 240 tablets per month. At $15 per month cash price for a standard-quantity fill, most pharmacies price this as one or two prescription fills. Confirm with your pharmacist whether a 240-tablet supply requires one prescription with quantity override or two separate fills.
Monitoring costs add to the overall picture. TSH and free T4 drawn every four to six weeks during titration at a Connecticut LabCorp or Quest site cost $30 to $80 per draw without insurance [13]. Aetna and Anthem typically cover these labs in full for members with a documented hyperthyroidism diagnosis code (ICD-10 E05.00 for Graves disease without thyroid storm). The NEJM Cooper 2005 paper notes that remission rates after 12 to 18 months of antithyroid drug therapy range from 20 to 30 percent per treatment cycle, meaning some patients proceed to radioiodine ablation or thyroidectomy and discontinue methimazole, while others require longer-term drug management [2].
Agranulocytosis, the most serious adverse effect, occurs in roughly 0.1 to 0.5 percent of patients according to a pooled analysis published in the Journal of Clinical Endocrinology and Metabolism [14]. Patients should be instructed to seek same-day evaluation and a complete blood count if they develop fever above 38.5 degrees Celsius or a severe sore throat at any point during therapy.
How Methimazole Compares to Propylthiouracil (PTU) on Cost and Access in Connecticut
Methimazole is the preferred antithyroid drug for nearly all adult patients with hyperthyroidism in Connecticut, as in the rest of the United States. PTU is reserved for the first trimester of pregnancy, thyroid storm, and patients with methimazole allergy or severe adverse reactions [2][4]. Generic PTU costs $20 to $35 per month at Connecticut pharmacies, slightly more than generic methimazole, and requires more frequent dosing at three times per day versus once or twice daily for methimazole [1].
The cost and convenience advantage of methimazole over PTU is consistent. A study of antithyroid drug prescribing patterns cited in the American Thyroid Association database found that methimazole accounts for over 90 percent of new antithyroid drug prescriptions in the United States [4]. That market dominance keeps generic methimazole supply high and pricing competitive at Connecticut pharmacies.
Patients switching from PTU to methimazole should have thyroid function rechecked two to four weeks after the switch, since bioavailability and potency differ between the two agents. The dose conversion is approximately 1 mg of methimazole for every 10 to 20 mg of PTU, though individual titration is always required [4].
Connecticut-Specific Pharmacy Access and Fill Locations
Connecticut has over 700 licensed retail pharmacies, including independent pharmacies that sometimes offer better cash pricing than chains for generic methimazole [15]. Independent pharmacies in cities like New Haven, Hartford, Bridgeport, and Stamford often participate in the National Community Pharmacists Association discount network, which can match or beat GoodRx pricing without requiring a coupon card download.
Mail-order pharmacies licensed in Connecticut, including Express Scripts, Optum Rx, and CVS Caremark (all operating under Connecticut DCP licensure), offer 90-day supplies. A 90-day generic methimazole fill at these mail-order pharmacies typically costs $25 to $35 cash, reducing the effective monthly cost to $8 to $12 per month, below the 30-day retail benchmark of $15 [15].
The FDA's drug shortage database shows no active shortage of methimazole as of early 2025, meaning Connecticut patients should not encounter supply disruptions at retail or mail-order pharmacies [6].
Patients transferring a methimazole prescription from an out-of-state prescriber to a Connecticut pharmacy should confirm the prescriber holds a valid Connecticut telehealth prescribing registration or an in-state license. The Connecticut Medical Examining Board maintains a public license verification portal.
Frequently asked questions
›How much does Methimazole (Tapazole) cost in Connecticut?
›Does Connecticut Medicaid cover Methimazole (Tapazole)?
›Is compounded methimazole legal in Connecticut?
›Can I get Methimazole (Tapazole) via telehealth in Connecticut?
›Which insurance plans cover Methimazole (Tapazole) in Connecticut?
›What's the cheapest way to get Methimazole (Tapazole) in Connecticut?
›Are there Connecticut Methimazole (Tapazole) discount programs?
›How does the Pfizer and generics savings card work in Connecticut?
References
- U.S. Food and Drug Administration. Tapazole (methimazole) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/006180s034lbl.pdf
- Cooper DS. Antithyroid drugs. N Engl J Med. 2005;352(9):905-917. https://pubmed.ncbi.nlm.nih.gov/15784668/
- Connecticut Department of Social Services. HUSKY Health formulary and prior authorization policies. https://health.ct.gov/programs/husky-health
- Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://pubmed.ncbi.nlm.nih.gov/27521067/
- U.S. Pharmacopeial Convention. USP Chapter 795: pharmaceutical compounding, nonsterile preparations. https://www.ncbi.nlm.nih.gov/books/NBK584222/
- U.S. Food and Drug Administration. Human drug compounding: 503A and 503B overview. https://www.fda.gov/drugs/human-drug-compounding/503a-outsourcing-facilities
- Connecticut General Assembly. An Act Concerning Telehealth Services (Public Act 21-9). https://www.cga.ct.gov/2021/act/Pa/pdf/2021PA-00009-R00SB-00819-PA.PDF
- Centers for Disease Control and Prevention. Chronic disease prevention and health promotion. https://www.cdc.gov/chronicdisease/index.htm
- Burch HB, Burman KD, Cooper DS. A 2011 survey of clinical practice patterns in the management of Graves disease. J Clin Endocrinol Metab. 2012;97(12):4549-4558. https://pubmed.ncbi.nlm.nih.gov/23043192/
- Gharib H, Papini E, Garber JR, et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract. 2016;22(Suppl 1):1-60. https://pubmed.ncbi.nlm.nih.gov/22443734/
- National Institutes of Health. MedlinePlus: methimazole drug information. https://www.ncbi.nlm.nih.gov/medlineplus/druginfo/meds/a682464.html
- Centers for Disease Control and Prevention. Prescription drug costs and access resources. https://www.cdc.gov/policy/polaris/healthtopics/prescriptiondrugs/index.html
- National Institutes of Health. TSH (thyroid-stimulating hormone) test: MedlinePlus medical test. https://www.ncbi.nlm.nih.gov/medlineplus/lab-tests/tsh-thyroid-stimulating-hormone-test/
- Watanabe N, Narimatsu H, Noh JY, et al. Antithyroid drug-induced hematopoietic damage: a retrospective cohort study of agranulocytosis and granulocytopenia. J Clin Endocrinol Metab. 2012;97(1):E49-53. https://pubmed.ncbi.nlm.nih.gov/22049174/
- National Community Pharmacists Association. Independent pharmacy locator and discount network. https://www.ncpa.org/